OTCMKTS:DYAI

Dyadic International Stock News

Healthcare > Biotechnology

Buy DYAI

*Your capital is at risk

$1.05

-0.0200 (-1.87%)

At Close: Jul 31, 2026

Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025

07:25am, Wednesday, 29'th Oct 2025

JUPITER, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. d/b/a Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a glob

Dyadic International Inc. (NASDAQ:DYAI) Sees Significant Growth in Short Interest

02:54am, Friday, 24'th Oct 2025

Dyadic International Inc. (NASDAQ: DYAI - Get Free Report) saw a large increase in short interest in September. As of September 30th, there was short interest totaling 158,000 shares, an increase of 6

Dyadic Applied BioSolutions Announces Milestone Achievements and Recent Company Developments

08:30am, Monday, 06'th Oct 2025

JUPITER, Fla., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc., d/b/a Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a glo

Dyadic to Present at Investor Conferences and BPI East

09:00am, Thursday, 04'th Sep 2025

JUPITER, Fla., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc., d/b/a Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a gl

Dyadic International, Inc. (DYAI) Q2 2025 Earnings Call Transcript

07:51pm, Wednesday, 13'th Aug 2025

Dyadic International, Inc. (NASDAQ:DYAI ) Q2 2025 Earnings Conference Call August 13, 2025 5:00 PM ET Company Participants Joseph P. Hazelton - President & COO Mark A.

Dyadic Reports Second Quarter 2025 Financial Results and Highlights of Recent Company Progress

04:01pm, Wednesday, 13'th Aug 2025

JUPITER, Fla., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused o

Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025

04:11pm, Tuesday, 05'th Aug 2025

JUPITER, Fla., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused o

UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

08:47am, Thursday, 31'st Jul 2025

JUPITER, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of hig

Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

07:30am, Thursday, 31'st Jul 2025

Dyadic International, Inc. Announces Proposed Public Offering of Common Stock

04:02pm, Wednesday, 30'th Jul 2025

JUPITER, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of hig

Dyadic International, Inc. Announces Strategic Rebrand to Dyadic Applied BioSolutions

04:00pm, Wednesday, 02'nd Jul 2025

JUPITER, Fla.--(BUSINESS WIRE)---- $DYAI #BioSolutions--Dyadic International, Inc. announces strategic rebrand to Dyadic Applied BioSolutions to reflect focus on commercializing non-therapeutic protei

Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications

08:35am, Monday, 02'nd Jun 2025

Rapid commercial validation has been achieved through key partnerships disrupting high value/high growth markets Leadership team realigned in order to enable execution of ancillary protein strategy Dy

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by